Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.2600
+0.0200 (8.32%)
Aug 27, 2025, 3:59 PM EDT

Northwest Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
3913648228306631,255
Upgrade
Market Cap Growth
-33.39%-55.72%-1.00%25.14%-47.13%870.89%
Upgrade
Enterprise Value
4704358818656861,270
Upgrade
Last Close Price
0.260.270.700.780.701.52
Upgrade
PE Ratio
----3.70-
Upgrade
PS Ratio
356.99263.35425.38493.23660.04971.84
Upgrade
PB Ratio
-4.51-4.61-17.47-7.90-5.35-3.46
Upgrade
EV/Sales Ratio
-314.92455.93513.96682.10983.37
Upgrade
Debt / Equity Ratio
-0.81-0.85-0.97-0.25-0.31-0.05
Upgrade
Asset Turnover
0.040.050.070.050.030.06
Upgrade
Quick Ratio
0.050.030.050.060.110.03
Upgrade
Current Ratio
0.070.060.090.080.130.04
Upgrade
Return on Assets (ROA)
-141.48%-152.28%-117.23%-117.48%-90.17%-248.63%
Upgrade
Earnings Yield
-21.39%-23.02%-7.62%-12.65%27.00%-42.23%
Upgrade
FCF Yield
-11.57%-15.95%-6.94%-6.71%-6.68%-3.08%
Upgrade
Buyback Yield / Dilution
-14.24%-10.99%-10.17%-0.79%-38.99%-28.53%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.